RUNX3 and astrocytoma (excluding glioblastoma): Functional assessment revealed putative-oncosupressive acting of RUNX3 in astrocytomas since gene is methylated and silenced in GBM cell lines and restoration of RUNX3 expression weighty reduced tumour cell viability.